در این مقاله بیماری ایدز با تابلوی بالینی پیچیده خود معرفی خواهد شد. ویروس HIV یا نقص ایمنی انسانی، مانند سایر ویروس ها، جهت چرخه حیات و تولید مثل خود به محیط درونی سلول نیاز دارد. میزبانان HIV در بدن بطور عمده سلول های سیستم ایمنی شامل لنفوسیت های T، سلول های کمک کننده T و مونوسیت ها می باشند . ویروس بصورت مؤثر سلول ها را بکار گرفته و از آن ها به عنوان ماشینی جهت اجرای دستورات ژنتیکی خود استفاده می کند تا ژنوم خود را تکثیر نماید.
Despite a history of championing HIV/AIDS as a human rights issue, and a rhetorical commitment to health as a human right, European states and institutions have shifted from a rights-based response to a risk management approach to HIV/AIDS since the economic recession of 2008. An
Harm reduction and HIV/AIDS in North America The emergence of the new disease, AIDS (first reported as a clinical syndrome in the USA in 1981), was the principal reason for the birth of harm reduction in the mid to late 1980s. The first appearance of clinical evidence of AIDS was
For over 15 years the Australian Agency for International Development (AusAID) has been a leading donor for harm reduction projects in Southeast Asia. The recent AusAID-supported harm reduction projects of greatest significance have included the Asia Regional HIV/AIDS Project (AH
Tobacco harm reduction (THR) – the substitution of low-risk tobacco/nicotine products for smoking and efforts to encourage such substitution – cannot be understood without understanding the motives and beliefs of consumers and how these affect action. Yet the discussion of THR ha